Sfoglia per AUTORE
POPAT S
Collezione AOU San Luigi di Orbassano

  

Items : 8

Anti-angiogenic agents for NSCLC following first-line immunotherapy: Rationale, recent updates, and future perspectives. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2023 May;179:107173. doi: 10.1016/j.lungcan.2023.03.009. Epub 2023 Mar 15.
2023
AOU San Luigi di Orbassano

Reck M; Popat S; Grohé C; Corral J; Novello S; Gottfried M; Brueckl W; Radonjic D; Kaiser R; Heymach J;

Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Jul;157:9-16. doi: 10.1016/j.lungcan.2021.05.017. Epub 2021 May 24.
2021
AOU San Luigi di Orbassano

Kruhl C; Bent-Ennakhil N; Pérol M; Hochmair M; Helland Å; Griesinger F; Garassino MC; Felip E; Cadranel J; Brustugun OT; Popat S; Novello S;

Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study. in JTO clinical and research reports / JTO Clin Res Rep. 2020 Oct 26;2(2):100114. doi: 10.1016/j.jtocrr.2020.100114. eCollection 2021 Feb.
2021
AOU San Luigi di Orbassano

Yang JC; Reckamp KL; Kim YC; Novello S; Smit EF; Lee JS; Su WC; Akerley WL; Blakely CM; Groen HJM; Bazhenova L; Carcereny Costa E; Chiari R; Hsia TC; Golsorkhi T; Despain D; Shih D; Popat S; Wakelee H;

Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer? in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jun;144:76-84. doi: 10.1016/j.lungcan.2020.04.009. Epub 2020 Apr 20.
2020
AOU San Luigi di Orbassano

Radonjic D; Gottfried M; Novello S; Reck M; Corral J; Grohé C; Popat S; Kaiser R;

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2020 Jun;15(6):914-947. doi: 10.1016/j.jtho.2020.03.006. Epub 2020 Mar 14.
2020
AOU San Luigi di Orbassano

Skoulidis F; Schalper KA; Popat S; Paz-Ares L; Mezquita L; Lu S; Kubota K; Horn L; Herbst RS; Goldberg SB; Gettinger S; Forde PM; Garon EB; Barlesi F; Ahn MJ; Passiglia F; Remon J; Reck M; Adjei AA; Scagliotti GV;

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275.
2018
AOU San Luigi di Orbassano

Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S;

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Sep;27(suppl 5):v1-v27. doi: 10.1093/annonc/mdw326.
2016
AOU San Luigi di Orbassano

Novello S; Barlesi F; Califano R; Cufer T; Ekman S; Levra MG; Kerr K; Popat S; Reck M; Senan S; Simo GV; Vansteenkiste J; Peters S;

2016
AOU San Luigi di Orbassano

Yang JC-H; Popat S; Novello S; Groen HJM; Perol M; Felip E; Griesinger F; Reckamp KL; Lee J-S; Smit EF; Blakely CM; Akerley WL; Kim Y-C; Bazhenova L; Califano R; Delmar Hall R; Georgiou P; Isaacson JD; Golsorkhi T; Wakelee HA;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte